High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible but for which patients?

摘要

Editorial will accompany Hermet et al. “Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin’s lymphoma: a French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study.”